FALLOPIAN TUBE CANCER STAGE III

FALLOPIAN TUBE CANCER STAGE III was reported 15 times

FALLOPIAN TUBE CANCER STAGE III is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 2 0.0001
1 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
2 Progesterone [EPC] 1 0.0000
3 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1 0.0000
4 Janus Kinase Inhibitor [EPC] 1 0.0000
5 Microtubule Inhibitor [EPC] 1 0.0000
6 Estrogen [EPC] 1 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
8 Proton Pump Inhibitor [EPC] 2 0.0000
9 Folate Analog Metabolic Inhibitor [EPC] 1 0.0000
10 GLP-1 Receptor Agonist [EPC] 1 0.0000
11 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
12 Corticosteroid [EPC] 2 0.0000
13 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000